Saying that humans will have to coexist with variations of COVID-19, a pharmaceutical company based in New Jersey plans to open a new production facility in Hamilton for the development of domestic vaccines, including those aimed at coronavirus.
The company, Tonix Pharmaceuticals Holding Corp. (TNXP), closed on 44 acres of land off Old Corvallis Road in Hamilton, where it plans to break ground on the new facility in late 2021.
The deal was brokered by Sterling Commercial Real Estate in Missoula and announced late Tuesday night. The news became public on Wednesday morning. Parsons Behle & Latimer also help negotiate the deal.
